Neuland Laboratories Limited (NSE:NEULANDLAB)
India
· Delayed Price · Currency is INR 12,123
+161 (1.35%)
Jun 27, 2025, 3:30 PM IST
Neuland Laboratories Revenue
In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B INR, down -5.24%. Neuland Laboratories had revenue of 3.28B in the quarter ending March 31, 2025, a decrease of -14.71%.
Revenue
14.77B
Revenue Growth
-5.24%
P/S Ratio
10.65
Revenue / Employee
8.99M
Employees
1,643
Market Cap
157.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.77B | -817.43M | -5.24% |
| Mar 31, 2024 | 15.59B | 3.67B | 30.81% |
| Mar 31, 2023 | 11.91B | 2.40B | 25.20% |
| Mar 31, 2022 | 9.52B | 147.07M | 1.57% |
| Mar 31, 2021 | 9.37B | 1.73B | 22.64% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |
Neuland Laboratories News
- 6 weeks ago - Neuland Laboratories share price drops 5% as Q4 EBITDA falls 52.3% YoY to Rs 51 crore - Business Upturn
- 2 months ago - Neuland Laboratories receives one FDA observation following inspection of Unit 2 facility in Telangana - Business Upturn
- 4 months ago - Neuland Laboratories shares drop 6% as Q3 EBITDA falls 29% YoY - Business Upturn
- 4 months ago - Neuland Laboratories Q3 FY25 Results: Net Profit surges 24.9% YoY, Revenue flat at Rs 398.03 crore - Business Upturn
- 5 months ago - Neuland Labs shares surge 3% after Rs 342 crore capex plan approval - Business Upturn
- 5 months ago - Top stocks to watch in trade today: Tech Mahindra, JSW Group, Neuland Labs, Railtel, PNB Housing and more - Business Upturn
- 5 months ago - Neuland Labs board approves Rs 342 crore capital expenditure - Business Upturn
- 7 months ago - Mixed trends in November CDRMO exports, prefer Syngene and Neuland Labs over Divis Labs and Laurus Labs - Business Upturn